|
Volumn 372, Issue 14, 2015, Pages 1374-1376
|
Multiple-system atrophy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GABAPENTIN;
NEUROPROTECTIVE AGENT;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
BOTULINUM TOXIN;
PREGABALIN;
SCOPOLAMINE;
TAMSULOSIN;
AUTONOMIC DYSFUNCTION;
CEREBELLUM CORTEX;
CEREBELLUM DISEASE;
CHRONIC DRUG ADMINISTRATION;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
DYSARTHRIA;
GAIT DISORDER;
HUMAN;
INFERIOR OLIVE;
LETTER;
NEUROCHEMISTRY;
OLIVOPONTOCEREBELLAR ATROPHY;
OSCILLOPSIA;
PATHOPHYSIOLOGY;
PONTINE NUCLEUS;
PRIORITY JOURNAL;
SHY DRAGER SYNDROME;
SINGLE DRUG DOSE;
SYMPTOM;
WEAKNESS;
ADD ON THERAPY;
ASPIRATION PNEUMONIA;
CEREBELLAR ATAXIA;
CONDOM;
DYSPHAGIA;
ENTERIC FEEDING;
EVENING DOSAGE;
FAINTNESS;
HYPERSALIVATION;
HYPOTENSION;
IMPAIRED BLADDER EMPTYING;
INTERMITTENT CATHETERIZATION;
ORTHOSTATIC HYPOTENSION;
SALIVATION;
UNSPECIFIED SIDE EFFECT;
URGE INCONTINENCE;
URINE RETENTION;
HUMANS;
MULTIPLE SYSTEM ATROPHY;
NEUROPROTECTIVE AGENTS;
|
EID: 84926329233
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1501657 Document Type: Letter |
Times cited : (79)
|
References (5)
|